|
| 36831373 | Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma. | Cancers (Basel) | 2023 |
| 36831373 | Combined Inhibition of IAPs and WEE1 Enhances TNFα- and Radiation-Induced Cell Death in Head and Neck Squamous Carcinoma. | Cancers (Basel) | 2023 |
| 37259923 | Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer. | J Clin Invest | 2023 |
| 37059104 | Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating TÂ cells following neoadjuvant immunotherapy in head and neck cancer. | Cancer Cell | 2023 |
| 37055579 | Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). | Cell Death Differ | 2023 |
| 37480219 | Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer. | Head Neck | 2023 |
| 37480219 | Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer. | Head Neck | 2023 |
| 37059104 | Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating TÂ cells following neoadjuvant immunotherapy in head and neck cancer. | Cancer Cell | 2023 |
| 37055579 | Inhibition of USP14 promotes TNFα-induced cell death in head and neck squamous cell carcinoma (HNSCC). | Cell Death Differ | 2023 |
| 37259923 | Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer. | J Clin Invest | 2023 |
| 35260537 | Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity. | JCI Insight | 2022 |
| 35727629 | Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer. | J Clin Invest | 2022 |
| 35260537 | Cure of syngeneic carcinomas with targeted IL-12 through obligate reprogramming of lymphoid and myeloid immunity. | JCI Insight | 2022 |
| 35176168 | Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. | Mol Cancer Res | 2022 |
| 35727629 | Enhanced neoepitope-specific immunity following neoadjuvant PD-L1 and TGF-β blockade in HPV-unrelated head and neck cancer. | J Clin Invest | 2022 |
| 35176168 | Inhibiting WEE1 and IKK-RELA Crosstalk Overcomes TNFα Resistance in Head and Neck Cancers. | Mol Cancer Res | 2022 |
| 34931021 | Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes. | Commun Biol | 2021 |
| 33737574 | Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. | Sci Rep | 2021 |
| 34931021 | Comprehensive multiomic characterization of human papillomavirus-driven recurrent respiratory papillomatosis reveals distinct molecular subtypes. | Commun Biol | 2021 |
| 33737574 | Death agonist antibody against TRAILR2/DR5/TNFRSF10B enhances birinapant anti-tumor activity in HPV-positive head and neck squamous cell carcinomas. | Sci Rep | 2021 |
| 30488488 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. | Mol Carcinog | 2019 |
| 31624067 | Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. | Cancer Immunol Res | 2019 |
| 30488488 | Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer. | Mol Carcinog | 2019 |
| 31266830 | Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. | Clin Cancer Res | 2019 |
| 31266830 | Dual Antagonist of cIAP/XIAP ASTX660 Sensitizes HPV<sup>-</sup> and HPV<sup>+</sup> Head and Neck Cancers to TNFα, TRAIL, and Radiation Therapy. | Clin Cancer Res | 2019 |
| 31624067 | Head and Neck Cancers Promote an Inflammatory Transcriptome through Coactivation of Classic and Alternative NF-κB Pathways. | Cancer Immunol Res | 2019 |
| 29511457 | Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells. | Am J Transl Res | 2018 |
| 29921694 | Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. | Cancer Res | 2018 |
| 30380422 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. | Cell Rep | 2018 |
| 29511457 | Downregulation of FoxM1 inhibits cell growth and migration and invasion in bladder cancer cells. | Am J Transl Res | 2018 |
| 29921694 | Attenuated TRAF3 Fosters Activation of Alternative NF-κB and Reduced Expression of Antiviral Interferon, TP53, and RB to Promote HPV-Positive Head and Neck Cancers. | Cancer Res | 2018 |
| 30380422 | Genomic and Transcriptomic Characterization Links Cell Lines with Aggressive Head and Neck Cancers. | Cell Rep | 2018 |
| 27132513 | TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. | Oncogene | 2016 |
| 27132513 | TNF-α modulates genome-wide redistribution of οNp63α/TAp73 and NF-κB cREL interactive binding on TP53 and AP-1 motifs to promote an oncogenic gene program in squamous cancer. | Oncogene | 2016 |
| 23455325 | Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. | Oncogene | 2014 |
| 25379016 | CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. | Neoplasia | 2014 |
| 24258200 | Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation. | J Pathol | 2014 |
| 23455325 | Aberrant IKKα and IKKβ cooperatively activate NF-κB and induce EGFR/AP1 signaling to promote survival and migration of head and neck cancer. | Oncogene | 2014 |
| 25379016 | CK2 phosphorylates and inhibits TAp73 tumor suppressor function to promote expression of cancer stem cell genes and phenotype in head and neck cancer. | Neoplasia | 2014 |
| 24258200 | Epidermal overexpression of transgenic οNp63 promotes type 2 immune and myeloid inflammatory responses and hyperplasia via NF-κB activation. | J Pathol | 2014 |
| 22641218 | TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. | Oncogene | 2013 |
| 22641218 | TGF-β and NF-κB signal pathway cross-talk is mediated through TAK1 and SMAD7 in a subset of head and neck cancers. | Oncogene | 2013 |
| 24069219 | Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma. | PLoS One | 2013 |
| 24069219 | Unraveling regulatory programs for NF-kappaB, p53 and microRNAs in head and neck squamous cell carcinoma. | PLoS One | 2013 |
| 21750205 | Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. | Clin Cancer Res | 2011 |
| 21576089 | οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. | Cancer Res | 2011 |
| 21750205 | Early tumor progression associated with enhanced EGFR signaling with bortezomib, cetuximab, and radiotherapy for head and neck cancer. | Clin Cancer Res | 2011 |
| 21933882 | TNF-α promotes c-REL/οNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. | Cancer Res | 2011 |
| 21933882 | TNF-α promotes c-REL/οNp63α interaction and TAp73 dissociation from key genes that mediate growth arrest and apoptosis in head and neck cancer. | Cancer Res | 2011 |
| 21576089 | οNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation. | Cancer Res | 2011 |